Buchert R - Search Results

1

Reliable quantification of ¹⁸F-GE-180 PET neuroinflammation studies using an individually scaled population-based input function or late tissue-to-blood ratio.

Buchert R, Dirks M, Schütze C, Wilke F, Mamach M, Wirries AK, Pflugrad H, Hamann L, Langer LBN, Wetzel C, Lukacevic M, Polyak A, Kessler M, Petrusch C, Bengel FM, Geworski L, Rupprecht R, Weissenborn K, Ross TL, Berding G. Buchert R, et al. Eur J Nucl Med Mol Imaging. 2020 Nov;47(12):2887-2900. doi: 10.1007/s00259-020-04810-1. Epub 2020 Apr 23. Eur J Nucl Med Mol Imaging. 2020. PMID: 32322915 Free PMC article.

2

Quality assurance in PET: evaluation of the clinical relevance of detector defects.

Buchert R, Bohuslavizki KH, Mester J, Clausen M. Buchert R, et al. J Nucl Med. 1999 Oct;40(10):1657-65. J Nucl Med. 1999. PMID: 10520706 Free article.

3

Effect of attenuation correction on lesion detectability in FDG PET of breast cancer.

Bleckmann C, Dose J, Bohuslavizki KH, Buchert R, Klutmann S, Mester J, Jänicke F, Clausen M. Bleckmann C, et al. Among authors: buchert r. J Nucl Med. 1999 Dec;40(12):2021-4. J Nucl Med. 1999. PMID: 10616880 Free article.

4

Performance evaluation of PET scanners: testing of geometric arc correction by off-centre uniformity measurement.

Buchert R, Bohuslavizki KH, Fricke H, Mester J, Clausen M. Buchert R, et al. Eur J Nucl Med. 2000 Jan;27(1):83-90. doi: 10.1007/pl00006668. Eur J Nucl Med. 2000. PMID: 10654152

5

Value of FDG PET in patients with fever of unknown origin.

Lorenzen J, Buchert R, Bohuslavizki KH. Lorenzen J, et al. Among authors: buchert r. Nucl Med Commun. 2001 Jul;22(7):779-83. doi: 10.1097/00006231-200107000-00009. Nucl Med Commun. 2001. PMID: 11453051 Clinical Trial.

6

Long-term effects of 'ecstasy' abuse on the human brain studied by FDG PET.

Buchert R, Obrocki J, Thomasius R, Väterlein O, Petersen K, Jenicke L, Bohuslavizki KH, Clausen M. Buchert R, et al. Nucl Med Commun. 2001 Aug;22(8):889-97. doi: 10.1097/00006231-200108000-00007. Nucl Med Commun. 2001. PMID: 11473208

7

FDG PET in the diagnosis of hilar cholangiocarcinoma.

Fritscher-Ravens A, Bohuslavizki KH, Broering DC, Jenicke L, Schäfer H, Buchert R, Rogiers X, Clausen M. Fritscher-Ravens A, et al. Among authors: buchert r. Nucl Med Commun. 2001 Dec;22(12):1277-85. doi: 10.1097/00006231-200112000-00002. Nucl Med Commun. 2001. PMID: 11711897

8

Long-term effects of "ecstasy" use on serotonin transporters of the brain investigated by PET.

Buchert R, Thomasius R, Nebeling B, Petersen K, Obrocki J, Jenicke L, Wilke F, Wartberg L, Zapletalova P, Clausen M. Buchert R, et al. J Nucl Med. 2003 Mar;44(3):375-84. J Nucl Med. 2003. PMID: 12621003 Free article.

9

Improved statistical power of the multilinear reference tissue approach to the quantification of neuroreceptor ligand binding by regularization.

Buchert R, Wilke F, van den Hoff J, Mester J. Buchert R, et al. J Cereb Blood Flow Metab. 2003 May;23(5):612-20. doi: 10.1097/01.WCB.0000060565.21994.07. J Cereb Blood Flow Metab. 2003. PMID: 12771577

10

Limitations of bi-linear regression analysis for the determination of receptor occupancy with positron emission tomography.

Buchert R, Varga J, Mester J. Buchert R, et al. Nucl Med Commun. 2004 May;25(5):451-9. doi: 10.1097/00006231-200405000-00005. Nucl Med Commun. 2004. PMID: 15100503 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

266 results

Search Page